Systemic Metabolic and Autophagy Pathways

Systemic metabolic and autophagy pathways represent the integrated network of biochemical processes that maintain cellular energy balance and structural integrity. These pathways are regulated by key molecular sensors, most notably the mechanistic target of rapamycin (mTOR) and adenosine monophosphate-activated protein kinase (AMPK), which coordinate anabolic and catabolic activities based on nutrient availability (Laplante & Sabatini, 2012, Cell). Autophagy, a core component of this system, facilitates the degradation of damaged organelles and proteins via the lysosome, providing essential building blocks during periods of starvation (Mizushima & Komatsu, 2011, Cell). Dysregulation of these interconnected processes is a fundamental driver of diverse pathologies, including metabolic syndrome, type 2 diabetes, neurodegenerative diseases, and various forms of cancer. Therapeutic intervention often targets specific nodes within these pathways to restore homeostasis, such as the use of metformin to activate AMPK or rapalogs to inhibit mTOR signaling (Hardie, 2011, Nat Rev Mol Cell Biol). However, because these pathways are essential for normal physiological function, pharmacological modulation requires precise dosing to avoid significant systemic toxicity or immunosuppression. Monitoring biomarkers like LC3-II levels or mTOR phosphorylation status is critical for assessing the efficacy of drugs targeting these pathways in clinical settings.

Other names

Metabolic-Autophagy AxisCellular Homeostasis PathwaysNutrient-Sensing NetworksMetabolic and Autophagic Signaling

Modulation of nutrient-sensing signaling complexes and lysosomal degradation processes to restore cellular energy balance and proteostasis.